Adherence to tuberculosis treatment among patients attending national tuberculosis elimination centre in tertiary care hospital, Bangalore


  • Julie K. John Department of Community Medicine, Rajarajeswari Medical College and Hospital, Bangalore, Karnataka, India
  • B. G. Parasuramalu Department of Community Medicine, Rajarajeswari Medical College and Hospital, Bangalore, Karnataka, India



Morisky medication adherence scale, Treatment adherence, Tuberculosis


Background: Annually ten million cases of tuberculosis (TB) and 1.8 million mortalities are recorded. Adherence to TB treatment not only reduces death outcomes but prevents prolonged sickness, transmission to others and development of multi drug resistant TB. This study was aimed at determining the rate of treatment adherence and possible factors influencing adherence to TB treatment in the NTEP Centre at Rajarajeswari medical college and hospital, Bangalore.

Methods: It was a cross sectional study design. A validated 8 item Morisky medication adherence scale was used to obtain data from respondents. Adherence to TB treatment was assessed. Chi square test was used to determine the variables that were associated with treatment adherence.

Results: Out of 60 patients, majority i.e. 18 (30%) were in the age group 25-34 years, males were more compared to females. Majority i.e. 21 (35%) were studied up to post high school diploma, 31(51.67%) were unemployed, majority i.e.  48 (80.00%) were married, 42 (70.00%) were from nuclear family. Out of 60 patients, majority 54 (90.00%) were Hindus 24 (40.00%) were from lower middle class.

Conclusions: The adherence rate for TB treatment in this study was 68.33%. There was no significant association between socio demographic variables, personal habits, health status, current TB status, type of TB, and common symptom with treatment adherence. An intensified health education on the adherence of TB treatment therefore recommended.


Bello SI, Itiola OA. Drug adherence amongst tuberculosis patients in the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Afr J Pharm Pharmacol. 2010;4(3):109-14.

Tuberculosis (TB). World Health Organization. Available from: 202021%2C%20an%20estimated%2010.6,TB%20is%20curable%20and%20preventable. Accessed on 9 July 2023.

Global Tuberculosis report 2022. World Health Organization; 2022. Available from: Accessed on 9 July 2023.

Yellappa V, Lefèvre P, Battaglioli T, Narayanan D, Van der Stuyft P. Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India. BMC Health Serv Res. 2016;16:1-1.

Park K. Park’s textbook of Preventive and Social Medicine.23rd edn. India: Bhanot Publishers; 2015.

Xu M, Markström U, Lyu J, Xu L. Detection of low adherence in rural tuberculosis patients in China: application of Morisky medication adherence scale. Int J Environ Res Public Health. 2017;14(3):248.

Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4(1):1-8.

De las Cuevas C, Peñate W. Psychometric Properties of the eight-item Morisky medication adherence scale (MMAS-8) in a psychiatric outpatient setting. Int J Clin Health Psychol. 2015;15(2):121-9.

Woimo TT, Yimer WK, Bati T, Gesesew HA. The prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study. BMC Public Health. 2017;17(1).

Dogah E, Aviisah M, Kuatewo DA, Kpene GE, Lokpo SY, Edziah FS. Factors Influencing Adherence to Tuberculosis Treatment in The Ketu North District of the Volta Region, Ghana. Tuberculosis research and treatment. 2021;30:2021.

Yadav RK, Kaphle HP, Yadav DK, Marahatta SB, Shah NP, Baral S, et al. Health related quality of life and associated factors with medication adherence among tuberculosis patients in selected districts of Gandaki Province of Nepal. J Clin Tubercul Other Mycobact Dise. 2021;23:100235.

Ubajaka CF, Azuike EC, Ugoji JO, Nwibo OE, Ejiofor OC, Modebe IA, et al. Adherence to drug medications amongst tuberculosis patients in a tertiary health institution in South East Nigeria. Int J Clin Med. 2015;06(06):399-406.

Bagchi S, Ambe G, Sathiakumar N. Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. Int J Prevent Med. 2010;1(4):223.

Gopi PG, Vasantha M, Muniyandi M, Balasubramanian R, Narayanan PR. Risk factors for non-adherence to directly observed treatment (DOT) in a rural tuberculosis unit, South India. Indian J Tubercul. 2007;54(2):66-70.

Widjanarko B, Gompelman M, Dijkers M, van der Werf MJ. Factors that influence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adhere. 2009:231-8.

Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC health services research. 2009 Dec;9:1-8.

Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among. Risk. 2002;62:10.




How to Cite

John, J. K., & Parasuramalu , B. G. (2023). Adherence to tuberculosis treatment among patients attending national tuberculosis elimination centre in tertiary care hospital, Bangalore. International Journal Of Community Medicine And Public Health, 10(12), 4788–4794.



Original Research Articles